Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne over Nine Years at a Large Italian Teaching Hospital
Year: 2015
Type: article
Abstract: Sensititre YeastOne (SYO) is an affordable alternative to the Clinical and Laboratory Standards Institute (CLSI) reference method for antifungal susceptibility testing. In this study, the MICs of yeast isolates from 1,214 bloodstream infection episodes, generated by SYO during hospital laboratory activity (January 2005 to December 2013), were reanalyzed using current CLSI clinical breakpoints/epidemiological cutoff values to assign susceptibility (or the wild-type [WT] phenotype) to systemic antifungal agents. Excluding Candida albicans (57.4% of all isolates [n = 1,250]), the most predominant species were Candida parapsilosis complex (20.9%), Candida tropicalis (8.2%), Candida glabrata (6.4%), Candida guilliermondii (1.6%), and Candida krusei (1.3%). Among the non-Candida species (1.9%), 7 were Cryptococcus neoformans and 17 were other species, mainly Rhodotorula species. Over 97% of Candida isolates were susceptible (WT phenotype) to amphotericin B and flucytosine. Rates of susceptibility (WT phenotype) to fluconazole, itraconazole, and voriconazole were 98.7% in C. albicans, 92.3% in the C. parapsilosis complex, 96.1% in C. tropicalis, 92.5% in C. glabrata, 100% in C. guilliermondii, and 100% (excluding fluconazole) in C. krusei. The fluconazole-resistant isolates consisted of 6 C. parapsilosis complex isolates, 3 C. glabrata isolates, 2 C. albicans isolates, 2 C. tropicalis isolates, and 1 Candida lusitaniae isolate. Of the non-Candida isolates, 2 C. neoformans isolates had the non-WT phenotype for susceptibility to fluconazole, whereas Rhodotorula isolates had elevated azole MICs. Overall, 99.7% to 99.8% of Candida isolates were susceptible (WT phenotype) to echinocandins, but 3 isolates were nonsusceptible (either intermediate or resistant) to caspofungin (C. albicans, C. guilliermondii, and C. krusei), anidulafungin (C. albicans and C. guilliermondii), and micafungin (C. albicans). However, when the intrinsically resistant non-Candida isolates were included, the rate of echinocandin nonsusceptibility reached 1.8%. In summary, the SYO method proved to be able to detect yeast species showing antifungal resistance or reduced susceptibility.
DOI: 10.1128/aac.00285-15
Authors: Brunella Posteraro, Teresa Spanu, Barbara Fiori, Flavio De Maio, Elena De Carolis, Alessia Giaquinto, Valentina Prete, Giulia De Angelis, Riccardo Torelli, Tiziana D'Inzeo, Antonietta Vella, Alessio De Luca, Mario Tumbarello, Walter Ricciardi, Maurizio Sanguinetti
Institution: Università Cattolica del Sacro Cuore
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: antifungal susceptibility, bloodstream infection, Candida, Sensititre YeastOne, Candida parapsilosis complex, Candida albicans, Candida tropicalis, Candida glabrata, Candida krusei, Cryptococcus neoformans, Rhodotorula, fluconazole resistance, echinocandin resistance, amphotericin B, 5-fluorocytosine, itraconazole, voriconazole, epidemiological cut-off values, antifungal susceptibility testing, Candida lusitaniae, Candida guilliermondii
Open Access status: green
OpenAlex ID: W1508443003
